Works by Marra, Fiona

Results: 18

Safe co‐administration of direct‐acting antivirals and direct oral anticoagulants among patients with hepatitis C virus infection: An international multicenter retrospective cohort study.

Published in:

Journal of Viral Hepatitis, 2022, v. 29, n. 12, p. 1073, doi. 10.1111/jvh.13750

By:

McDaniel, Kathryn;
Utz, Alyssa E.;
Akbashev, Mikhail;
Fuller, Katherine G.;
Boyle, Alison;
Davidson, Katherine;
Marra, Fiona;
Shah, Sital;
Cartwright, Emily J.;
Arora, Aakriti A.;
DuPont, Sarah;
Miller, Lesley S.

Publication type:

Article

Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis.

Published in:

2020

By:

Lampertico, Pietro;
Mauss, Stefan;
Persico, Marcello;
Barclay, Stephen T.;
Marx, Steven;
Lohmann, Kristina;
Bondin, Mark;
Zhang, ZhenZhen;
Marra, Fiona;
Belperio, Pamela S.;
Wedemeyer, Heiner;
Flamm, Steven

Publication type:

Correction Notice

Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis.

Published in:

2020

By:

Lampertico, Pietro;
Mauss, Stefan;
Persico, Marcello;
Barclay, Stephen T.;
Marx, Steven;
Lohmann, Kristina;
Bondin, Mark;
Zhang, ZhenZhen;
Marra, Fiona;
Belperio, Pamela S.;
Wedemeyer, Heiner;
Flamm, Steven

Publication type:

journal article

Drug-Drug Interactions With Novel All Oral Interferon- Free Antiviral Agents in a Large Real-World Cohort.

Published in:

Clinical Infectious Diseases, 2016, v. 62, n. 5, p. 561, doi. 10.1093/cid/civ973

By:

zu Siederdissen, Christoph Höner;
Maasoumy, Benjamin;
Marra, Fiona;
Deterding, Katja;
Port, Kerstin;
Manns, Michael P.;
Cornberg, Markus;
Back, David;
Wedemeyer, Heiner

Publication type:

Article

Are UK pharmacists ready for consultant-level practice? A cross-sectional survey of self-assessed development needs.

Published in:

International Journal of Pharmacy Practice, 2022, v. 30, n. 6, p. 559, doi. 10.1093/ijpp/riac070

By:

Forsyth, Paul;
Radley, Andrew;
Marra, Fiona;
Roberts, Debra;
Sehrawat, Michele;
Aiello, Matthew;
Brown, Jane;
Rauchhaus, Petra;
Doherty, Stephen;
Parsons, Rachael;
Oakley, Joseph;
Bond, Christine;
Roberts, Susan

Publication type:

Article

GLOBAL COLLABORATION TO PROVIDE DRUG INTERACTION GUIDANCE FOR NIRMATRELVIR/RITONAVIR.

Published in:

Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 202

By:

Kuriakose, Safia;
Tseng, Alice;
Gibbons, Sara;
Marra, Fiona;
Boyle, Alison;
Senneker, Tessa;
Eschenauer, Gregory;
Boyd, Sarita;
George, Jomy;
Scarsi, Kimberly K.;
Khoo, Saye;
Pau, Alice K.;
Marzolini, Catia

Publication type:

Article

Drug interactions: a review of the unseen danger of experimental COVID-19 therapies.

Published in:

2020

By:

Hodge, Catherine;
Marra, Fiona;
Marzolini, Catia;
Boyle, Alison;
Gibbons, Sara;
Siccardi, Marco;
Burger, David;
Back, David;
Khoo, Saye

Publication type:

journal article

COVID‐19 treatment in patients with comorbidities: Awareness of drug‐drug interactions.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 1, p. 212, doi. 10.1111/bcp.14358

By:

Back, David;
Marzolini, Catia;
Hodge, Catherine;
Marra, Fiona;
Boyle, Alison;
Gibbons, Sara;
Burger, David;
Khoo, Saye

Publication type:

Article

Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medications.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 961, doi. 10.1111/bcp.13519

By:

Marra, Fiona;
Höner zu Siederdissen, Christoph;
Khoo, Saye;
Back, David;
Schlag, Michael;
Ouwerkerk‐Mahadevan, Sivi;
Bicer, Ceyhun;
Lonjon‐Domanec, Isabelle;
Jessner, Wolfgang;
Beumont‐Mauviel, Maria;
Kalmeijer, Ronald;
Cornberg, Markus

Publication type:

Article

Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications.

Published in:

Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1191, doi. 10.1002/cpt.2646

By:

Marzolini, Catia;
Kuritzkes, Daniel R.;
Marra, Fiona;
Boyle, Alison;
Gibbons, Sara;
Flexner, Charles;
Pozniak, Anton;
Boffito, Marta;
Waters, Laura;
Burger, David;
Back, David J.;
Khoo, Saye

Publication type:

Article

Frequency of Potential Drug–Drug Interactions in the Changing Field of HCV Therapy.

Published in:

Open Forum Infectious Diseases, 2020, v. 7, n. 2, p. N.PAG, doi. 10.1093/ofid/ofaa040

By:

Schulte, Benjamin;
Wübbolding, Maximilian;
Marra, Fiona;
Port, Kerstin;
Manns, Michael P;
Back, David;
Cornberg, Markus;
Stichtenoth, Dirk O;
Siederdissen, Christoph Höner zu;
Maasoumy, Benjamin

Publication type:

Article

Eight weeks of sofosbuvir/velpatasvir for genotype 3 hepatitis C in previously untreated patients with significant (F2/3) fibrosis.

Published in:

Journal of Viral Hepatitis, 2020, v. 27, n. 4, p. 371, doi. 10.1111/jvh.13239

By:

Boyle, Alison;
Marra, Fiona;
Peters, Erica;
Datta, Shouren;
Ritchie, Trina;
Priest, Matthew;
Heydtmann, Mathis;
Barclay, Stephen T.

Publication type:

Article

Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and psychiatric disorders: An integrated analysis.

Published in:

Journal of Viral Hepatitis, 2019, v. 26, n. 8, p. 951, doi. 10.1111/jvh.13110

By:

Back, David;
Belperio, Pamela;
Bondin, Mark;
Negro, Francesco;
Talal, Andrew H.;
Park, Caroline;
Zhang, ZhenZhen;
Pinsky, Brett;
Crown, Eric;
Mensa, Federico J.;
Marra, Fiona

Publication type:

Article

Real‐world safety and effectiveness of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C virus genotype 1‐ and 4‐infected patients with diverse comorbidities and comedications: A pooled analysis of post‐marketing observational studies from 13 countries

Published in:

Journal of Viral Hepatitis, 2019, v. 26, n. 6, p. 685, doi. 10.1111/jvh.13080

By:

Ferenci, Peter;
Bourgeois, Stefan;
Buggisch, Peter;
Norris, Suzanne;
Curescu, Manuela;
Larrey, Dominique;
Marra, Fiona;
Kleine, Henning;
Dorr, Patrick;
Charafeddine, Mariem;
Crown, Eric;
Bondin, Mark;
Back, David;
Flisiak, Robert

Publication type:

Article

Correction to: Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir.

Published in:

2021

By:

Aghemo, Alessio;
Horsmans, Yves;
Bourgeois, Stefan;
Bondin, Mark;
Gschwantler, Michael;
Hofer, Harald;
Semmo, Nasser;
Negro, Francesco;
Zhang, Zhenzhen;
Marcinak, John;
Veitsman, Ella;
Hazzan, Rawi;
Mimidis, Konstantinos;
Goulis, Ioannis;
Marques, Nuno;
Flisiak, Robert;
Mazur, Wlodzimierz;
Roncero, Carlos;
Marra, Fiona;
Pageaux, Georges Philippe

Publication type:

Correction Notice

Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir.

Published in:

Infectious Diseases & Therapy, 2021, v. 10, n. 4, p. 2203, doi. 10.1007/s40121-021-00455-1

By:

Aghemo, Alessio;
Horsmans, Yves;
Bourgeois, Stefan;
Bondin, Mark;
Gschwantler, Michael;
Hofer, Harald;
Semmo, Nasser;
Negro, Francesco;
Zhang, Zhenzhen;
Marcinak, John;
Veitsman, Ella;
Hazzan, Rawi;
Mimidis, Konstantinos;
Goulis, Ioannis;
Marques, Nuno;
Flisiak, Robert;
Mazur, Wlodzimierz;
Roncero, Carlos;
Marra, Fiona;
Pageaux, Georges Philippe

Publication type:

Article

Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions.

Published in:

2022

By:

Marzolini, Catia;
Kuritzkes, Daniel R.;
Marra, Fiona;
Boyle, Alison;
Gibbons, Sara;
Flexner, Charles;
Pozniak, Anton;
Boffito, Marta;
Waters, Laura;
Burger, David;
Back, David;
Khoo, Saye

Publication type:

Editorial

Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment.

Published in:

Drugs in R&D, 2021, v. 21, n. 1, p. 9, doi. 10.1007/s40268-020-00333-0

By:

Marra, Fiona;
Smolders, Elise J.;
El-Sherif, Omar;
Boyle, Alison;
Davidson, Katherine;
Sommerville, Andrew J.;
Marzolini, Catia;
Siccardi, Marco;
Burger, David;
Gibbons, Sara;
Khoo, Saye;
Back, David

Publication type:

Article